U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 result

HALO's Q2 earnings and revenues surpass estimates, fueled by higher royalties and product sales. The

Wall Street analysts changed ratings & price targets for top stocks. Check out all changes inclu

Halozyme Therapeutics NASDAQ: HALO reported record second-quarter revenue and raised its full-year o

Halozyme Therapeutics, Inc. (HALO) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Halozyme Therapeutics (HALO) give a sense of how its business perfo

Halozyme Therapeutics (HALO) came out with quarterly earnings of $2.28 per share, beating the Zacks

Total Revenue Increased 48% YOY to $481 million Royalty Revenue Increased 50% YOY to $308 million Ra

Amundi boosted its holdings in Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 503.5% during the undef

This medical technology name has a patented method of drug delivery. Halozyme stock recently hit a r

Halozyme (HALO) has delivered ~134% price appreciation since my prior 'Buy' rating in 06/2023. I eva

Halozyme Therapeutics, Inc. (NASDAQ: HALO - Get Free Report) shares reached a new 52-week high on Fr

SAN DIEGO, July 23, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") tod

Halozyme Therapeutics, Inc. (HALO) shares gain 539% since first Big Money outlier inflow signal in M

Halozyme grants ENHANZE rights to Incyte for developing subcutaneous cancer therapy formulations, ai

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ

Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR developm

Fifth Third Bancorp increased its holdings in Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 4,206.4%

ARCO, HALO, TX and ARRY screen as high-earnings-yield value picks as the Middle-East conflict sharpe

HALO stocks are gaining favor as investors rotate toward tangible assets and AI-resistant businesses

Wall Street is caught in the midst of shifting geopolitical stances of the United States and Iran, c

SAN DIEGO, June 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t

SAN DIEGO, June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ

Agreement provides Takeda with exclusive access to ENHANZE® drug delivery technology for vedolizumab

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

  On Tuesday, 164 companies hit new 52-week lows.

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

  On Monday, 61 companies hit new 52-week lows.

  Friday's session saw 100 companies set new 52-week lows.

  On Thursday, 498 companies reached new 52-week lows.

  On Thursday, 185 companies achieved new lows for the year.

  On Wednesday, 345 companies set new 52-week lows.

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f